Cover Image
Market Research Report
Product code 
981955

Asia Pacific Autoinjectors Market By Type, By Application, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

Published: | KBV Research | 97 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Autoinjectors Market By Type, By Application, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026
Published: December 31, 2020
KBV Research
Content info: 97 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Asia Pacific Autoinjectors Market would witness market growth of 19.1% CAGR during the forecast period (2020-2026).

Most of the autoinjectors are single-use, disposable, spring-loaded syringes. The autoinjectors are designed in such a way that it makes them easy to use and are planned for self-administration by patients, or delivered by even untrained personnel. The place of injection mainly depends on the drug-loaded, but it is usually administered into either thigh or buttocks. Auto-injectors are favored over conventional devices because they allow efficient and enhanced drug delivery even in new formulations. The advancement of technology in products are estimated to boost growth.

Market growth is mainly driven by the increasing incidences of targeted therapies, the increasing occurrence of anaphylaxis, growing inclination for self-administration of drugs. Further, the usability benefits, the growing number of governing approvals, and the accessibility of standard versions of autoinjectors, favorable settlements pertaining to the autoinjectors is fuelling the market. In addition, government's provision as well as technological advancements are likely to turn this market more opportunistic. The patent termination of biologics is also anticipated to deliver growth opportunities for the market.

The growth of the market in the Asia Pacific market is largely due to the large number of patients suffering from chronic allergies and diabetes as well as increasing healthcare expenditure. This in turn has drawn a number of key auto-injector device manufacturers to this region. These companies are showing more presence in the Asia Pacific market via several approaches, including partnering with local pharmaceutical companies and establishing sales offices.

Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Disposable autoinjectors
  • Reusable autoinjectors

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Other Applications

By End Use

  • Hospitals & Clinics
  • Home care settings

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Autoinjectors Market, by Type
    • 1.4.2 Asia Pacific Autoinjectors Market, by Application
    • 1.4.3 Asia Pacific Autoinjectors Market, by End Use
    • 1.4.4 Asia Pacific Autoinjectors Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Approvals
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May - 2020, Nov) Leading Players

Chapter 4. Asia Pacific Autoinjectors Market by Type

  • 4.1 Asia Pacific Disposable autoinjectors Market by Country
  • 4.2 Asia Pacific Reusable autoinjectors Market by Country

Chapter 5. Asia Pacific Autoinjectors Market by Application

  • 5.1 Asia Pacific Anaphylaxis Market by Country
  • 5.2 Asia Pacific Rheumatoid Arthritis Market by Country
  • 5.3 Asia Pacific Multiple Sclerosis Market by Country
  • 5.4 Asia Pacific Other Application Market by Country

Chapter 6. Asia Pacific Autoinjectors Market by End Use

  • 6.1 Asia Pacific Hospitals & Clinics Autoinjectors Market by Country
  • 6.2 Asia Pacific Home care settings Autoinjectors Market by Country

Chapter 7. Asia Pacific Autoinjectors Market by Country

  • 7.1 China Autoinjectors Market
    • 7.1.1 China Autoinjectors Market by Type
    • 7.1.2 China Autoinjectors Market by Application
    • 7.1.3 China Autoinjectors Market by End Use
  • 7.2 Japan Autoinjectors Market
    • 7.2.1 Japan Autoinjectors Market by Type
    • 7.2.2 Japan Autoinjectors Market by Application
    • 7.2.3 Japan Autoinjectors Market by End Use
  • 7.3 India Autoinjectors Market
    • 7.3.1 India Autoinjectors Market by Type
    • 7.3.2 India Autoinjectors Market by Application
    • 7.3.3 India Autoinjectors Market by End Use
  • 7.4 South Korea Autoinjectors Market
    • 7.4.1 South Korea Autoinjectors Market by Type
    • 7.4.2 South Korea Autoinjectors Market by Application
    • 7.4.3 South Korea Autoinjectors Market by End Use
  • 7.5 Singapore Autoinjectors Market
    • 7.5.1 Singapore Autoinjectors Market by Type
    • 7.5.2 Singapore Autoinjectors Market by Application
    • 7.5.3 Singapore Autoinjectors Market by End Use
  • 7.6 Malaysia Autoinjectors Market
    • 7.6.1 Malaysia Autoinjectors Market by Type
    • 7.6.2 Malaysia Autoinjectors Market by Application
    • 7.6.3 Malaysia Autoinjectors Market by End Use
  • 7.7 Rest of Asia Pacific Autoinjectors Market
    • 7.7.1 Rest of Asia Pacific Autoinjectors Market by Type
    • 7.7.2 Rest of Asia Pacific Autoinjectors Market by Application
    • 7.7.3 Rest of Asia Pacific Autoinjectors Market by End Use

Chapter 8. Company Profiles

  • 8.1 Eli Lilly and Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Geographical Expansions:
  • 8.2 GlaxoSmithKline PLC (GSK)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.1 Recent strategies and developments:
      • 8.2.1.1 Approvals:
  • 8.3 Merck Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Sanofi S.A.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Approvals:
      • 8.4.5.3 Product Launches and Product Expansions:
  • 8.5 Becton, Dickinson and Company
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
  • 8.6 Teva Pharmaceutical Industries Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Approvals:
  • 8.7 Amgen, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Research & Development Expense
    • 8.7.4 Recent strategies and developments:
      • 8.7.4.1 Product Launches and Product Expansions:
  • 8.8 Ypsomed AG
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
  • 8.9 AbbVie, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
  • 8.10. Biogen, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 ASIA PACIFIC AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- AUTO-INJECTORS MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 5 GEOGRAPHICAL EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 6 APPROVALS- AUTO-INJECTORS MARKET
  • TABLE 7 ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 8 ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 9 ASIA PACIFIC DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 ASIA PACIFIC DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 ASIA PACIFIC REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 ASIA PACIFIC REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 14 ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 15 ASIA PACIFIC ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 16 ASIA PACIFIC ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 17 ASIA PACIFIC RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 ASIA PACIFIC RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 ASIA PACIFIC OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 ASIA PACIFIC OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 24 ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 25 ASIA PACIFIC HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 ASIA PACIFIC HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 ASIA PACIFIC HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 28 ASIA PACIFIC HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 29 ASIA PACIFIC AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 ASIA PACIFIC AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 CHINA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 32 CHINA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 33 CHINA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 34 CHINA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 35 CHINA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 36 CHINA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 37 CHINA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 38 CHINA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 39 JAPAN AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 40 JAPAN AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 41 JAPAN AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 42 JAPAN AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 43 JAPAN AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 44 JAPAN AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 45 JAPAN AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 46 JAPAN AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 47 INDIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 48 INDIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 49 INDIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 50 INDIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 51 INDIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 52 INDIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 53 INDIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 54 INDIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 55 SOUTH KOREA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 56 SOUTH KOREA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 57 SOUTH KOREA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 58 SOUTH KOREA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 59 SOUTH KOREA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 60 SOUTH KOREA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 61 SOUTH KOREA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 62 SOUTH KOREA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 63 SINGAPORE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 64 SINGAPORE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 65 SINGAPORE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 66 SINGAPORE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 67 SINGAPORE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 68 SINGAPORE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 69 SINGAPORE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 70 SINGAPORE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 71 MALAYSIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 72 MALAYSIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 73 MALAYSIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 74 MALAYSIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 75 MALAYSIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 76 MALAYSIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 77 MALAYSIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 78 MALAYSIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 79 REST OF ASIA PACIFIC AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 80 REST OF ASIA PACIFIC AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 81 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 82 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 83 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 84 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 87 KEY INFORMATION - ELI LILLY AND COMPANY
  • TABLE 88 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 89 KEY INFORMATION - MERCK GROUP
  • TABLE 90 KEY INFORMATION - SANOFI S.A.
  • TABLE 91 KEY INFORMATION - BECTON, DICKINSON AND COMPANY
  • TABLE 92 KEY INFORMATION - TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • TABLE 93 KEY INFORMATION - AMGEN, INC.
  • TABLE 94 KEY INFORMATION --YPSOMED AG
  • TABLE 95 KEY INFORMATION - ABBVIE, INC.
  • TABLE 96 KEY INFORMATION - BIOGEN, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, MAY - 2020, NOV) LEADING PLAYERS
  • FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: ELI LILLY AND COMPANY
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: SANOFI S.A.
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: BECTON, DICKINSON AND COMPANY
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: TEVA PHARMACEUTICALS INDUSTRIES LTD.